Advanced hepatocellular carcinoma: which staging systems best predict prognosis? - Wikidata - awgldk - TriplyDB

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

http://www.wikidata.org/entity/Q36836103

about

Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments Liver resection for intermediate hepatocellular carcinoma Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment Comparison of hepatocellular carcinoma in Eastern versus Western populations.Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort Reassessing hepatocellular carcinoma staging in a changing patient population.Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma.International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)Determinants of survival after sorafenib failure in patients with BCLC-C hepatocellular carcinoma in real-world practice Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective study.Expression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significance Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101 Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomy Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection.Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma.

P2860

Q26743666-41E6E17F-7FBA-47CD-AAC8-BB255AC8AC0C Q26748756-39980A84-2FEC-45E0-91E8-13D7074A461E Q26797643-E4B11A1C-2152-4A8B-94AA-D7FA67C24B06 Q28079378-9A1D5C40-A331-4017-AC51-C3F6B19597E7 Q30245396-D794178A-C86D-4676-A236-5D2FE5E0814A Q33572657-8CA5AFE9-008A-402F-8AC7-E769316D5A2F Q33767286-32B443A3-9D84-4940-AFF2-E0E5D9D89F61 Q33912315-1B71BEE3-E01A-4A42-82C2-B551440BD138 Q34104067-97DBE23C-8A0B-4CD8-AAA0-7D3903804857 Q34346779-CED085DA-CB44-4F75-98BB-BB76C9FE083D Q34446810-F6167AF3-8712-4491-B3FC-AAD710F2E1BC Q34510569-B20E5CA9-A4B4-4C8C-8745-21563E0123A7 Q34572243-946FE089-57D8-4CE5-8520-7C7DD071AA58 Q34733478-9749322B-9DC3-4323-B64A-1496CFB0AB16 Q34959939-0668AD05-719F-428B-9ED0-509DC2C30B2C Q35038304-C0ECE515-15C8-4B4E-A6DD-6971BF17AD8E Q35109504-664391AF-3C75-452C-979A-BC0E3C0B9EB4 Q35113002-7AF7F968-E75D-4C66-B206-70E5AB4984BB Q35114970-F052D906-B357-478E-BF7B-62EA84C1A173 Q35208826-337632E5-1FE1-4E5B-A99B-7A17F449477B Q35241955-2CDC5644-C44C-40EC-BAA9-FA6963F77B05 Q35289603-2935E5B4-1C6D-4595-984B-1542CD7195F9 Q35594248-590BDA5B-8496-4C82-AAE3-1377B4FDF59D Q35629299-E177BD9D-2779-4C89-BCFD-607C203EB98D Q35889913-AFB0C36A-317B-4497-A449-B0DA82E40AA0 Q36009272-72914200-5E6D-4BEE-8A44-8E37DD479D54 Q36069902-916DBAFB-7D1D-444A-BEE9-7636813BD2BF Q36095161-7C2C8424-00E0-4A25-BBC3-A079985D2469 Q36102833-4F86991F-8CC0-44EB-AF6F-634CFCA3BA95 Q36182882-73BC6E78-8AA2-4965-A567-2D886F2AE38C Q36194925-A253A9DE-705E-4412-92E7-3F786E6245D7 Q36265439-66E29BC4-1804-4A62-9FDC-034200467ECD Q36299107-26240DED-3806-4FB6-AE7F-127EEE1B2A82 Q36327007-15713971-F036-4F5D-8D6E-B6978BDF0912 Q36385705-C9490CA7-CC3F-45F1-AD64-D724AE6CF60E Q36392831-0CE5E3D7-1936-4CAA-A9DC-5D3799542B80 Q36414399-1B7A71BC-A350-4CDC-A582-7836F33A56E2 Q36741673-618A0D59-5EB3-496E-9BEE-B67093597B33 Q36942342-E1B45781-389D-4D1F-964F-186D341B3E79 Q37154953-D24695B8-78EF-492D-8493-6B6CE2B371FE

P2860

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

http://www.wikidata.org/entity/Q36836103

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

@en

type

label

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

@en

prefLabel

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

@en

P1433

Q36836103-92CDD13C-E01E-43C1-A55C-496F102BD35E

P1476

Q36836103-241774D2-6EEE-49FA-A56D-7E494E519E01

P2093

Q36836103-4B63AC76-6813-41B3-A909-26CAB748CDCF

Q36836103-4F200186-6E88-4E06-BF7B-D9BE14AE4089

Q36836103-8050EB17-FF2E-493D-A2BA-7CE1EF9FA55F

Q36836103-9EDDD545-9F26-4FA6-829E-D577A6998E65

Q36836103-F78C60DB-63C3-48C6-A3DC-630250E6768C

P2860

Q36836103-00D0DFDB-C2B7-4801-AAD1-412D4711CA45

Q36836103-0331AE92-1387-40C8-8666-03DAD54F46EF

Q36836103-14DB09F3-9B04-4B4E-BBC2-68AF7BD8709D

Q36836103-15C4A997-F92D-4181-9E32-9D78A26B00C5

Q36836103-182E3832-16F1-43D4-91CE-752CBAA82506

Q36836103-269490DD-CBF3-4770-B4BF-2AAB57C8F136

Q36836103-500DEF64-3CBD-4375-8A0A-AB1EA87AF3BC

Q36836103-5FDE960D-0D9B-468A-9E18-1479DA5BAB88

Q36836103-702D4946-13D8-41A7-8CB0-89E2F4394863

Q36836103-7C7D34A2-CA5F-40D9-A2F9-01B4897AF419

P304

Q36836103-2739AC76-CFAA-46C7-8EAD-49FCF9B95F0C

P31

Q36836103-01411905-6729-481D-B99B-ADD2CA728060

P356

Q36836103-22F6BE31-57C0-426D-83B5-741A0F17D781

P407

Q36836103-6A7DADC4-7B5F-43CB-970F-F2BEA21C4F03

P433

Q36836103-5761DD44-C7D3-405A-9394-A8EEF028EFA2

P478

Q36836103-43DFE49B-DF38-458B-A245-E52FBA2F788A

P50

Q36836103-68DE0B3A-54CF-4F68-B0D8-52775C68C731

Q36836103-AD9CAF4B-1479-4859-AD68-D148E7C254DE

P577

Q36836103-637DEC7B-91F4-4B1D-9CF6-BE1A8D2E4F6D

P698

Q36836103-5872A8C0-BF9E-4BC3-9C36-83B076EA947B

P932

Q36836103-A36125EA-758C-44BB-93C4-3EF10F8C3365

P356

JCO.2009.25.9895

P1433

Journal of Clinical Oncology

P1476

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

@en

P2093

Austin Duffy

http://www.w3.org/2001/XMLSchema#string

Bolorsukh Gansukh

http://www.w3.org/2001/XMLSchema#string

Fidel-David Huitzil-Melendez

http://www.w3.org/2001/XMLSchema#string

Ghassan K Abou-Alfa

http://www.w3.org/2001/XMLSchema#string

Marinela Capanu

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.

P304

2889-2895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.25.9895

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Leonard B. Saltz

Eileen M O'Reilly

P577

2010-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20458042

http://www.w3.org/2001/XMLSchema#string

P932

3651603

http://www.w3.org/2001/XMLSchema#string